Logo
S

Scipher Medicine

68 employees

Scipher Medicine is building the future of patient treatment. Most patients who are prescribed blockbuster therapies today don’t respond to the treatment, costing the health care industry billions in wasted drugs while patients continue to suffer. Scipher's platform identifies which drug will work based on the patient's fundamental disease biology, and not based on symptoms, disease classification, or medical bias. A simple test predicts which drug he/she will respond to, ensuring that most optimal treatment is prescribed from day one. The molecular data generated by our tests is then used to fuel novel target discovery to address a clear unmet medical need in patients who do not respond to any existing therapy.

Investor insights

Funding rounds participated in

$110M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

2015

Funding rounds raised

Total raised

$110M

from 2 investors over 1 rounds

S

Scipher Medicine raised $110M on March 24, 2022

Investors: Cowen Healthcare Investments and + 10 Other investors

FAQ